1. Home
  2. BEAM vs WNS Comparison

BEAM vs WNS Comparison

Compare BEAM & WNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAM
  • WNS
  • Stock Information
  • Founded
  • BEAM 2017
  • WNS 1996
  • Country
  • BEAM United States
  • WNS India
  • Employees
  • BEAM N/A
  • WNS N/A
  • Industry
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • WNS Business Services
  • Sector
  • BEAM Health Care
  • WNS Consumer Discretionary
  • Exchange
  • BEAM Nasdaq
  • WNS Nasdaq
  • Market Cap
  • BEAM 1.9B
  • WNS 2.1B
  • IPO Year
  • BEAM 2020
  • WNS N/A
  • Fundamental
  • Price
  • BEAM $27.18
  • WNS $54.65
  • Analyst Decision
  • BEAM Buy
  • WNS Buy
  • Analyst Count
  • BEAM 11
  • WNS 7
  • Target Price
  • BEAM $45.90
  • WNS $60.43
  • AVG Volume (30 Days)
  • BEAM 1.2M
  • WNS 665.0K
  • Earning Date
  • BEAM 11-05-2024
  • WNS 10-17-2024
  • Dividend Yield
  • BEAM N/A
  • WNS N/A
  • EPS Growth
  • BEAM N/A
  • WNS N/A
  • EPS
  • BEAM N/A
  • WNS 2.50
  • Revenue
  • BEAM $349,643,000.00
  • WNS $1,308,696,000.00
  • Revenue This Year
  • BEAM N/A
  • WNS N/A
  • Revenue Next Year
  • BEAM $9.04
  • WNS $7.96
  • P/E Ratio
  • BEAM N/A
  • WNS $21.88
  • Revenue Growth
  • BEAM 328.73
  • WNS 2.07
  • 52 Week Low
  • BEAM $18.85
  • WNS $39.85
  • 52 Week High
  • BEAM $49.50
  • WNS $72.57
  • Technical
  • Relative Strength Index (RSI)
  • BEAM 60.47
  • WNS 67.79
  • Support Level
  • BEAM $21.46
  • WNS $46.50
  • Resistance Level
  • BEAM $27.30
  • WNS $49.21
  • Average True Range (ATR)
  • BEAM 1.28
  • WNS 1.54
  • MACD
  • BEAM 0.45
  • WNS 1.02
  • Stochastic Oscillator
  • BEAM 80.54
  • WNS 98.95

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

About WNS WNS (Holdings) Limited Sponsored ADR (Jersey)

WNS (Holdings) Ltd is a Global provider of business process management (BPM) services, offering comprehensive data, voice, analytical, and business transformation services with a blended onshore, nearshore and offshore delivery model. The company's segment includes Banking/Financial Services, and Insurance; Travel, Shipping/Logistics, and Utilities; Manufacturing/Retail/Consumer, Hi-tech/Professional Services, and Procurement; Healthcare/Life Sciences. Geographically the company generates the majority of its revenue from North America (primarily the US), followed by the UK. The company also has a presence in Australia, Europe (excluding the UK), and South Africa.

Share on Social Networks: